Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Andy Wells Publicatons May 2016

171 views

Published on

  • The #1 Woodworking Resource With Over 16,000 Plans, Download 50 FREE Plans... ♣♣♣ http://tinyurl.com/yy9yh8fu
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • Get access to 16,000 woodworking plans, Download 50 FREE Plans... ★★★ http://ishbv.com/tedsplans/pdf
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • Want to preview some of our plans? You can get 50 Woodworking Plans and a 440-Page "The Art of Woodworking" Book... Absolutely FREE ▲▲▲ http://ishbv.com/tedsplans/pdf
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • Be the first to like this

Andy Wells Publicatons May 2016

  1. 1. Dr Andrew S Wells Publications, Patents, Invited Presentations etc. May 2016 Publications 88) Rebecca E. Meadows, Keith R. Mulholland, Martin Schürmann, Michael Golden, Hans Kierkels, Elise Meulenbroeks, Daniel Mink, Oliver May, Christopher Squire, Harrie Straatman andAndrew S. Wells Efficient Synthesis of (S)-1-(5-Fluoropyrimidin-2-yl)ethylamine using an ω-Transaminase Biocatalyst in a Two-Phase System Practical Methods for Biocatalysis and Biotransformations 3, Wiley 2016 87). Biocatalysis for Medical Chemistry Green and Sustainable Medicinal Chemistry: Methods, Tools and Strategies for the 21st Century Pharmaceutical Industry Series: RSC Green Chemistry 2016. 86). Inês P. Rosinha, Søren Heintz, Ulrich Krühne, Krist V. Gernaey, Patrick Adlercreutz, Andy S. Wells and John M. Woodley ‘Considerations for selection of organic solvents applied to biphasic systems for in-situ product recovery and downstream processing in bioprocesses’ Green Chemistry submitted for publication. 85). Andrew S Wells, John W Wong, Peter C Michels, Dave Entwistle, Keith Fandrick, Gregory L Finch, Animesh Goswami, Heewon Lee, Stefan Mix, Thomas S. Moody, Long Pang, Robert K Sato, Nicholas J Turner, and Timothy J Watson. ‘Case Studies illustrating a science and risk- based approach to ensuring drug quality when using enzymes in the manufacture of Active Pharmaceuticals Ingredients for oral dosage form.’ Organic Process Research and Development, 2016, 2016, 20 (3), pp 594–601 84). D. Lathbury and A. Wells ‘Oxidation and Oxidative Reactions’ Organic Process Research and Development, 2015 special edition on oxidation Org. Process Res. Dev. 2015, 19, 1536−1536. 83). Denis Prat, Andy Wells, John Hayler, Helen Sneddon, C. Robert Mc Elroy, Sarah Abou- Shehadad and Peter J. Dunn CHEM21 Selection Guide of Classical – and Less Classical – Solvents. Green Chemistry, 2016, 18, 288-296. 82). Chungang Gu,Richard J. Lewis, Andrew Wells, Per H. Svensson, Vinayak P. Hosagrahara, Eskil Johnsson, and Gösta Hallström "Lipid peroxide mediated oxidative rearrangement of the pyrazinone carboxamide core of neutrophil elastase inhibitor AZD9819 in blood plasma samples.’ Drug Metabolism and Disposition, 2015, Oct;43(10):1441-1449. 81). ‘Some Reflections on Solvent Selection’ ACS Nexus blog Jan 2015 https://communities.acs.org/community/science/sustainability/green-chemistry-nexus- blog/blog/2015/01/26/some-reflections-on-solvent-selection 80). ‘Meet the Green Team’ – The Medicine Maker, March 11th, 2015 Issue 0215, 2015 https://themedicinemaker.com/issues/a-better-pill-to-swallow/meet-the-green-team/
  2. 2. 79). Christopher P. Ashcroft, Peter J. Dunn, John D. Hayler, Andrew S. Wells ‘Survey of Solvent Usage in Papers Published in Organic Process Research and Development 1997-2012.’ Organic Process Research and Development, 2015, 19, 740-747. 78). Denis Prat, John Hayler and A Wells ‘A Survey of Solvent Selection Guides’ Green Chemistry– 2014,16, 4546-4551. 77). K. Deplanche, J. A. Bennett, I.P.Mikheenko, J. Omajali, A. S. Wells, R. E. Meadows, J. Wood and L. E. Macaskie Catalytic activity of biomass-supported Pd nanoparticles: influence of the biological component in catalytic efficacy and potential application in ‘green’ synthesis of fine chemicals and pharmaceuticals -Applied Catalysis B- Environmental, 2014, 147, 651-665. 76). N. J. Turner and Andy Wells ‘The Enzyme Spring: Biocatalysis at its Best’ ChemCatChem, 2014, 6, 900. 75). Andy Wells and Hans-Peter Meyer ‘Biocatalysis as a Strategic Green Technology for the Chemical Industry’ ChemCatChem, 2014, 6, 918. 74). Julia A. Griffen, Jenifer C. White, Gabriele Kociok-Köhn, Matthew D. Lloyd, Andrew Wells, Tom C. Arnot and Simon E. Lewis New Aminocyclitols with Quaternary Stereocenters via Acylnitroso Cycloaddition with an ipso, ortho-Arene Dihydrodiol Tetrahedron, 2013, 69, 5989–5997. 73). Rebecca E. Meadows, Keith R. Mulholland, Martin. Schürmann, Michael Golden, Hans Kierkels, Oliver May, Elizabeth Meulenbroeks, Daniel Mink, Oliver May , Christopher Squire , Hans Straatman, Andrew S.Wells Efficient Synthesis of (S)-1-(5-Fluoropyrimidin-2-yl)ethylamine using an ω-Transaminase Biocatalyst in a Two-Phase System Organic Process Research and Development, 2013, 17, 1117–1122 72). Lianne Frodsham, Michael Golden, Susan Hard, Martin N. Kenworthy, David J. Klauber, Kevin Leslie,Claire Macleod, Rebecca E. Meadows, Keith R. Mulholland, Julie Reilly, Christopher Squire, Simone Tomasi, Denise Watt, and Andrew S. Wells ‘Use of ω‑ Transaminase Enzyme Chemistry in the Synthesis of a JAK2 Kinase Inhibitor Organic Process Research and Development, 2013, 17, 1123–1130 71). Andrew S. Wells, Gregory L. Finch, Peter C. Michels, and John W. Wong ‘Use of Enzymes in the Manufacture of Active Pharmaceutical Ingredients—A Science and Safety-Based Approach To Ensure Patient Safety and Drug Quality’ Organic Process Research and Development, 2012, 16, 1986. 70). L. Amarnath, Ian Andrews, Rakeshwar Bandichhor, Apurba Bhattacharya, Peter Dunn, John Hayler, William Hinkley, Nicole Holub, David Hughes, Luke Humphreys, Bernard Kaptein, Hare Krishnen, Kurt Lorenz, SujuMathew, G. Nagaraju, Thomas Rammeloo, Paul Richardson, Lijun Wang, Andrew Wells, Timothy White Green Chemistry Articles of Interest to the Pharmaceutical Industry’ Organic Process Research and Development, 2012, 16, 535. 69). Mark Dow, Rhona Sinclar, Rebecca Meadows, Andrew Wells Dynamic kinetic resolution of α- halo esters with hydrolytic enzymes and sec-amine bases Practical Methods for Biocatalysis and Biotransformation Volume 2, Wiley 2012.
  3. 3. 68). Neil Barnwell and Andrew Wells Asymmetric synthesis of quaternary amino acids from simple bis nitriles using a dual nitrile hydratase/amidase biocatalyzed reaction ‘ Practical Methods for Biocatalysis and Biotransformation Volume 2, Wiley 2012. 67). J. Adams, I. Archer, D. Auriol, M. Avi, K. Baldenius, C. Branneby, A.Collis, B. Dumas, T. Eckrich, I. Fotheringham, S. Hallon, M. Hassen, K. Holt-Tiffin, R. Howard, G. Huisman, H. Iding, M. Kittelmann, K. Laumen, E. Kupfer, F. Lefevre, S. Luetz, V. Martin, H-P. Myer, T. Moody, A. Osorio- Lozada, K. Robbins, P. Sutton, M. Truppo, A. Wells, J. Wong, B. Wirz ‘Biocatalysis in the Fine Chemical and Pharmaceutical Industries: An Industrial Perspective’ Practical Methods for Biocatalysis and Biotransformation Volume 2, Wiley 2012. 66). Ian Andrews , Peter Dunn , John Hayler , Bill Hinkley , David Hughes , Berard Kaptein , Kurt Lorenz , Suju Mathew, , Thomas Rammeloo , Lijun Wang , Andrew Wells , Timothy D. White ‘Green Chemistry Articles of Interest to the Pharmaceutical Industry’ Organic Process Research and Development, 2011, 15, 748. 65). Ian Andrews, Peter Dunn, John Hayler, Bill Hinkley, David Hughes, Bernard Kaptein, Kurt Lorenz, Suju Mathew, Thomas Rammeloo, Lijun Wang, Andrew Wells, and Timothy Donald White Green Chemistry Articles of Interest to the Pharmaceutical Industry’ Organic Process Research and Development, 2011, 15, 22. 64). Ian Andrews, Jian Cui, Leo Dudin, Peter Dunn, John Hayler, Bill Hinkley, David Hughes, Bernard Kaptein, Kurt Lorenz, Suju Mathew, Thomas Rammeloo, Lijun Wang, Andrew Wells, Timothy Donald White Green Chemistry Articles of Interest to the Pharmaceutical Industry’ Organic Process Research and Development, 2010, 14, 770. 63). Concepción Jiménez-González, Peter Poechlauer, Rinus Broxterman, Bing-Shiou Yang, David am Ende, James Baird, Carl Bertsch, Robert E. Hannah, Phil Dell'Orco, Henk Noorman, Sandy Yee, Raf Reintjens, Andrew Wells, Viviane Massonneau, Gjalt Hiusman and John Hayler ‘ Key Green Engineering Research Areas for Sustainable Manufacturing —A perspective from pharmaceutical and fine chemicals manufacturers’ Organic Process Research and Development, 2011, 15, 900.45. 62). ‘On the Perils of Unexpected Silane Generation’ Organic Process Research and Development, 2010, 14, 484. 61). ‘Industrial Applications of BioCatalysis: An Overview’ Comprehensive Chirality, Volume 9, pp. 253-287. Amsterdam: Elsevier, 2012. 60). ‘The use of Continuous Processing to Make AZD4407 Intermediates’, Pharmaceutical Process Chemistry, Pub. Wiley 2010. 59). ‘Biocatalytic Routes to the Large Scale Synthesis of Lotrafiban’, Asymmetric Catalysis on Industrial Scale 2nd ed. Pub. Wiley 2010. 58). Lee Proctor, Peter Dunn, Joel Hawkins, Andy Wells, and Mike Williams ‘Continuous Processing in the Pharmaceutical Industry’ Chapter 11, Green Chemistry in the Pharmaceutical Industry, Pub. Wiley, 2010.
  4. 4. 57). Peter Dunn, Andy Wells, and Mike Williams’ Future Trends’ Chapter 16, Green Chemistry in the Pharmaceutical Industry, Pub. Wiley, 2010. 56). Geoffrey R, Akien, Jean-Christophe Legeay, Andrew Wells, and Martyn Poliakoff ‘The Continuous Catalytic Debenzylation of p-dibenzyloxybenzene with H2 in THF Expanded with High Pressure CO2 ‘ Organic Process Research and Development, 2010, 14, 1201. 54). Karim Engelmark, Cassimjee, Cecilia Branneby, Vahak Abedi, Andrew Wells, Per Berglund ‘Transaminations with isopropyl amine: Equilibrium displacement with yeast alcohol dehydrogenase coupled to in situ cofactor regeneration’ Chemical Communications , 2010, 5569. 53). Ian Andrews, Jian Cui, Jimmy DaSilva, Leo Dudin, Peter Dunn, John Hayler, Bill Hinkley, David Hughes, Bernard Kaptein, Kurt Lorenz, Suju Mathew, Thomas Rammeloo, Lijun Wang, Andrew Wells, Timothy White, and Fuyao Zhang ‘Green Chemistry Articles of Interest to the Pharmaceutical Industry’ Organic Process Research and Development, 2010, 14, 19. 52). Ian Andrews, Jian Cui, Jimmy DaSilva, Leo Dudin, Peter Dunn, John Hayler, Bill Hinkley, David Hughes, Bernard Kaptein, Stanley Kolis, Kurt Lorenz, Suju Mathew, Thomas Rammeloo, Lijun Wang, Andrew Wells, Timothy White, Chaoyu Xie, Fuyao Zhang ‘Green Chemistry Articles of Interest to the Pharmaceutical Industry’ Organic Process Research and Development, 2009, 13, 397. 51). ‘The Green Movement-Rethinking Chemistry’ Pharmavoice, Sept 2008 50). S. Challenger, L. Dudin, J. DaSilva, P. Dunn, T. Govaerts, J. Hayler, B. Hinkley, Y. Houpis, T. Hunter, L. Jellet, J. L. Leazer, K. Lorenz, S. Mathew, T. Rammeloo, R. Sudini, Z. Wan, C. Welch, A. Wells, J. Vance, C. Xie, F. Zhang ‘Green Chemistry Highlights’ Organic Process Research and Development, 2008, 12, 807. 49). Peter Clark, Martyn Poliakoff and Andrew Wells, ‘Continuous Flow Hydrogenation of Pharmaceutical Intermediate, [4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalenyidene methyl amine, in Supercritical Carbon Dioxide’ Advances in Synthesis and Catalysis, 2007, 439, 2655. 48). Charlotte Wiles, Gillian M. Greenway, Paul Watts, Andy Wells, Linda L. Woodcock and Steve Eyley‘Optimised Enzymatic Synthesis of a Series of Alkyl Esters using Novozyme 435 in a Packed-Bed, Miniaturised, Continuous Flow Reactor’ Biocatalysis & Biotransformation, 2008, 26, 501. 47). David C. Constable, Peter J. Dunn, John Hayler, John Leazer, Russell J. Linderman, Kurt Lorenz, Julie Manley Bruce Pearlman, Andrew Wells, Aleksey Zaks, Tony Y. Zhang, ‘Key Green Chemistry Research Areas – A Perspective From Pharmaceutical Manufacturers’ Green Chemistry, 2007, 9, 411. 298. 46). D. Blackmond, A. Armstrong, V. Coombe, A. Wells ‘Water in Organocatalytic processes: Debunking the Myths’ Angew. Chem. Int. Ed. 2007, 46, 3798.
  5. 5. 45). T.S.C. Eve, N. Turner and Andrew Wells ‘Enantioselective Oxidation of O-methyl – N- Hydroxylamines using Monoamine Oxidase N as a Catalyst’ Chemical Communications, 2007,1530. 44). ‘Enzymes at Work’ Chemical & Engineering News, 2006, 84, (33) 43). ‘Biocatalysis for Greener Transformations’ Speciality Chemicals, 2006, 26, (10), p24. 15. 42). Vyv Coombe and Andrew Wells ‘On the Freshwater Ecotoxicity and Biodegredation of some Common Ionic Liquids’, Organic Process Research and Development, 2006, 10, 794. 41). Neil Barnwell, Lal Cheema, Janette Cherryman, JérÔme Dubiez, Garnet Howells and Andrew Wells ‘Selective Lipase-Catalysed Hydrolysis of a 1,2-Diester in the Development of a New Route to AZD2563 DSP’ Organic Process Research and Development, 2006, 10, 644. 40). ‘What’s in a Biocatalyst?’ Organic Process Research and Development, 2006, 10, 678. 39). Andy Wells, Tom Eve and Maira Teria ‘ Green Oxidations using Laccase –Mediator Systems’ Biochemical Society Transactions, 2006, 34, 2, 304. 38). Richard J. Atkins, Adam Banks, Richard K. Bellingham, Gary F. Breen, John S. Carey, Stephen K. Etridge, Jerome F. Hayes, Nigel Hussain, David O. Morgan, Paul Oxley, Stephen C. Passey, Timothy C. Walsgrove, and Andrew S. Wells , ‘The Development of a Manufacturing Route for the GPIIb/IIIa Receptor Antagonist SB-214857-A. Part 2: Conversion of the Key Intermediate SB-235349 to SB-214857-A’ Organic Process Research and Development, 2003, 7, 663. 37). Richard J. Atkins, Gary F. Breen, David O. Morgan, Andrew C. Share, Stephen A. C. Smith, Timothy C. Walsgrove and Andrew S. Wells, ‘Development of an Efficient Manufacturing Route to Methyl 2,3,4,5-tetrahydro-4-methyl-3-oxo-1H-benzodiazepine-2-acetate SB-235349, a Key Intermediate in the Synthesis of Lotrafiban’, Organic Process Research and Development, 2003, 7, 655. 36). M. Alston, A. Willetts and A. Wells ‘Polymer-Supported Catalase - the Green Approach to the Removal of Hydrogen Peroxide from Reaction Mixtures’ Organic Process and Development, 2002, 6, 505. 35). J-P Baptiste, J. Hayes, H. Seldrake, P. Sheldrake, and A .S. Wells ‘Synthesis of SB 214857 using Copper-Catalysed amination of aryl bromides with L-Aspartic Acid’ Syn. Letts., 2001, 1423. 34). L .Powell, T. Walsgrove and A. Wells, ‘A Practical and Robust Process to Produce SB- 214857 'Lotrafiban ' ((2S)-7-(4,4' -Bipiperidinylcarbonyl)-2,3,4,5-tetrahydro-4-methyl-3-oxo-1H- 1,4-benzodiazepine-2-acetic acid) Utilising an Enzymic Resolution as the Final Step’ Organic Process Research and Development, 2002, 6, 488. 33). Ian Andrews, Richard Atkins, Richard F Bellingham, Gary Breen, John S Cary, Stephen K. Smith, Jerome F. Hayes, Nigel Hussain, David O. Morgan, Andrew Share, Stephen Smith, Timothy C.
  6. 6. Walsgrove, Andrew Wells, ‘A New Synthesis of the GPIIb/IIIa Receptor Antagonist SB 214857- A’ Tet. Letts., 2001, 42, 4915. 32). E. Le Carre, N. Lewis, C. Ribas and A. Wells, ‘Convenient Preparation of Functionalised Polymer-based Resins via an Economical Preparation of Chloromethylated Polystyrene Resins (Merrifield type)’ Organic Process Research and Development, 2000, 4, 606. 31). N. Lewis, C. Ribas and A. Wells, ‘A Highly Efficient Preparation of Methacrylate Esters using Novel Solid Phase Titanium -based Transesterification Catalysts’ Syn.Lett., 1999, 957. 30). S. Etridge, J. Hayes, T. Walsgrove and A. Wells, ‘A New and Convergent Synthesis of (2S)-7- (4,4'-bipiperidinylcarbonyl)-2,3,4,5-tetrahydro-4-methyl-3-oxo-1H-1,4-Benzodiazepine-2-Acetic Acid using a Palladium Catalysed Aminocarbonylation Reaction’ Organic Process Research and Development, 1999, 3, 60. 29). J. A. Blackie, N. J. Turner and A. S. Wells, ‘Concerning the Baker's Yeast (Saccharomyces cerevisiae) Mediated Reduction of Nitroarenes and other N-O Containing Groups’ Tet.Letts.,1 997, 38, 3043. 28). ‘Sodium bis(2-methoxyethoxy)aluminium hydride in Petroleum Ether; A Reagent for the Selective Reduction of Brominated Fatty Esters to Bromoalcohols’ Synthetic Commun., 1996, 26, 1143. 27). I. P. Andrews, N. J. Lewis, A. McKillop and A. S. Wells, ‘Oxidation of Substituted Pyridines PyrCHRSiMe3 and Substituted Quinolines QnCH2RSiMe3 with Hypervalent Iodine Reagents’ Heterocycles,1996, 43, 1151. 26). I. P. Andrews, R. Bannister, S. K. Etridge, V. M. Mullane and A. S. Wells, ,Phosphorus Mediated Cyclisation of a beta-Aminoacrylamide to a Quinoline:a Simple Synthesis of SK&F 96067’ Tet.Letts., 1995, 36, 7743. 25). I. P. Andrews, N. J. Lewis, A. McKillop and A. S. Wells, ‘Oxidation of Substituted Pyridines PyrCH2X(X =H,COOR,COC6H5) with Hypervalent Iodine Reagents’ Heterocycles, 1994, 38, 713. 24). C. Davey, L. Powell, N. J. Turner and A. Wells, ‘Regioselective Reduction of Substituted Dinitroarenes using Baker's Yeast’ Tet.Letts., 1994, 35, 7867. 23). ‘A Convenient Synthesis of Ttriaryl and Trialkyl Phosphine Dichlorides by Oxidation of Tertiary Phosphines with Bis(trichloromethyl)carbonate('Triphosgene')’ Synthetic Commun., 1994, 24, 1715. 22). C. L. Davey, L. W. Powell, .J. Turner and A. Wells, ‘Regioselective Reduction of Disubstituted Dinitroarenes using Baker's Yeast’ Preparative Biotransformations, 2:8:9. Pub. Wiley 1995.
  7. 7. 21). C. L. Davey, L. W. Powell, N. J. Turner and A. Wells, ‘Baker's Yeast Reductions of Aromatic Nitro Compounds to Aromatic Amines’ Preparative Biotransformations, 2:8:1. Pub. Wiley 1995. 20). A. Houlton, R. M. G. Roberts, J. Silver and A. S. Wells, ‘Structures of Arene - Cyclopentadienyl Iron(II) Salts:Benzene-Cyclopentadienylethyl Ketone Iron (II) Hexafluorophosphate’, Acta Crystallogr.,Sec.C:Cryst.Struct.Commun. 1992, c48, 1081. 19). A. S. Wells, P. W. Sheldrake, I. Lantos and D. Eggleston, ‘Unexpected Synthesis of a 1H- Pyrrolo{2,3-e]-1,2,4-Triazine’ J. Chem. Soc.Perkin Trans.1,1991, 1762. 18). I. Lantos, P. W. Sheldrake and A. S .Wells, ‘Novel Cage compounds from Inter-and Intramolecular Diels-Alder Reactions of Heteroaromatic Azadienes and Methyl Coumalate with Cyclo-1,5-octa-1,5-diene’ J.Chem.Soc.Perkin Trans. 1, 1990, 1887. 17). R. M. G. Roberts, J. Silver and A. S. Wells, ‘A Study of Acylmonophosphaferrocenes in Strong Acids’ Inorg.Chim.Acta, 1989, 157, 45. 16). R. M. G. Roberts, J. Silver and A. S. Wells, ‘Mossbauer and NMR Spectroscopic Studies of Diphosphaferrocenes in Trifluoromethanesulphonic Acid’ Inorg .Chim. Acta, 1986, 119, 1. 15). R. M. G. Roberts, J. Silver and A. S. Wells, ‘Structural studies of protonated monophosphaferrocenes using Mossbauer and NMR spectroscopy’ Inorg. Chim. Acta, 1986, 118, 135. 14). R. M. G. Roberts, J. Silver and A. S. Wells, ‘Complexes of Diphosphaferrocenes with Lewis acids and Copper(1) Silver(1) Salts’ Inorg. Chim. Acta, 1986, 119, 165. 13). R. M. G. Roberts and A. S. Wells, ‘Trifluoromethanesulphonic Acid as a Catalyst in the Acylation of Phosphaferrocenes’ Inorg. Chim. Acta, 1986, 112, 167. 12). B. Lucas, R. M. G. Roberts and A. S. Wells, ‘Mossbauer Studies on Ferrocene Complexes IX, Phosphaferrocences and their Protonated Derivatives’ J. Organomet. Chem, 1983, 256, 103. 11). R. M. G. Roberts and A. S. Wells, ‘A New Synthetic Route to Monophosphaferrocenes’ Inorg. Chim.Acta, 1986, 112, 171. 10). R. M. G. Roberts, J. Silver and A. S. Wells, ‘An Iron-57 Mossbauer Study of Phospaferricenuim Ions’ Inorg. Chim. Acta, 1987, 126, 561. 9). R. M. G. Roberts, J. Silver and A. S. Wells, ‘The Formation and Spectroscopic Identification of some Alpha-Phosphaferrocenyl Carbenium Ions’ Inorg. Chim. Acta, 1989, 155, 197. 8). I. Lantos, P. W. Sheldrake and Andrew Wells, ‘Novel Cage Compounds from Inter-intra Molecular Diels-Alder Reactions of 1,2,4-Triazines with Cycloocta-1,5-diene’ J .Chem. Soc. Chem.Commun., 1988, 1482. 7). R. M .G. Roberts, J. Silver, A. S. Wells and S. P. Willkinson, ‘Synthesis and Structure of Biphenyl-Cyclopentadienyl Iron(II) Hexafluorophosphates’, J.Organomet.Chem, 1987, 327, 247.
  8. 8. 6). A. Houlton, G. K. Ofori-Okai, R. M. G. Roberts, J. Silver and A. S. Wells, ‘An Iron-57 Mossbauer Study of Arene-Cyclopentadienyl Iron(II) Salts’ J.Organomet.Chem., 1987, 326, 217. 5). R. M. G. Roberts and A. S. Wells, ‘Fridel-Crafts Acetylations of Alkyl-and Phenylphosphaferrocenes’ Inorg. Chim. Acta, 1987, 130, 93. 4). R. M. G. Roberts and A. S. Wells, ‘Aluminium Chloride Induced Cleavage of Diphosphaferrocenes in Aromatic Hydrocarbons; the Synthesis of Arene/Phosphacyclopentadienyl Iron(II) Cations’ Inorg. Chim. Acta, 1987, 126, 67. 3). R. M. G. Roberts and A .S. Wells, ‘Acid-Catalysed Ketone Rearrangements of t-Butanoyl Substituted Arene/Cyclopentadienyl Iron(II) Cations’ J.Organomet.Chem., 1986, 317, 233. 2). R. M. G. Roberts and A. S. Wells ’The Cleavage of Cyclopentadienyl -Substituted Arene/Cyclopentadienyl Iron(II) Cations by Phospholyl Anions. A Facile Route to 1'-Substituted Monophosphaferrocenes’ Inorg. Chim.Acta, 1986, 120, 53. 1).R. M. G. Roberts, J. Silver and A. S. Wells, ‘Mossbauer and NMR Studies of Protonated Acyldiphosphaferrocenes’ Inorg. Chim. Acta, 1986, 119, 171. Patents 14). Aesica Pharmaceuticals Ltd and CatScl Limited and Charnwood Technical Consulting Limited ‘Process’ UK application No. GB1500277.7. 13). D. Ainge, R. Sinclair, L. Vaz, A. Wells ‘Preparation of intermediates ((R )-2,2,4-trimethyl- 1,3-dioxolane-4-yl) methanol, 3-fluoro-4-nitro-phenol, and 1-(4-chloro-benzyl)piperidin-4- ylamine’ WO 2009035407. 12). N. Barnwell, L-E Briggner, P.Cornwall, A. Wells Preparation of (5S)-5-[4-(5-chloro-pyridin- 2-yloxy)-piperidine-1-sulfonylmethyl]-5-methyl-imidazolidine-2,4-dione as a Metalloproteinase Inhibitor and its Crystal Modification WO 2007106022. 11). S. Wildeman and Andrew Wells ‘New Process for Converting Aromatic Halo-Substituted Dinitriles into Halo-Substituted Cyanocarboxylic Acids’ WO 2007035161 A1 2007. 10). J. Moseley, J. Gilday, D. Brown, A. Wells ‘Chemoenzymic Synthesis of 3-phenyl-2- arylalkylthiopropionic acid Derivatives’ WO 2006064213 A2. 9). David Crowe, Neil Ward and Andrew Wells, ‘Process for the Preparation of Paroxetine’ WO 0129031. 8). David Crowe, Neil Ward and Andrew Wells, ‘A Novel Processes for the Manufacture of Paroxetine’ WO 0129032. 7). ‘Novel Gemifloxacin Hydrochloride salt Formation’ GB Patent application 9820404.3, 6). J. Hayes, T. Walsgrove and A. Wells, ‘Preparation of a Naphthyridine Carboxylic acid Methanesulfonate Sesquihydrate’ WO 200017199.
  9. 9. 5). Separation of Gemifloxacin Enantiomers, GB Patent application 9820403.5 4). ‘Enzymic Resolution of Benzodiazepine Acetic Acid Esters’ WO 98/29561. 3). S. Etridge, J. Hayes, T. Walsgrove, A. Wells, ‘Process for the Aminocarbonylation of Benzazepines and Benzodiazapines’ WO 97/24336. 2). A. Wells and N. Lewis ‘Preparation of Haloalkyl Methacrylate Monomers’ WO 91/ 09005. 1).A. Wells, N. Lewis, T. Walsgrove, P. Oxley, J. Fortunak ‘Process for the Preparation of Substituted Indolone Derivatives (eg Ropinrole’)’ WO 94/15918. Invited Presentations and Posters etc 71). ‘Medicinal vs. process chemistry routes’ Sustainable Chemistry in Industry, Durham University, UK November 2015. 70). ‘Solvents - Optimising Choice and Minimising Impact’ Solvents Day University of York 30th April 2015. 69). Current successes and future challenges for green chemistry in the pharmaceutical industry’, Green Chemistry for Pharma, ACIB, Graz, Austria, Sept 2014. 68). Emma Lampard, Janet Scott, Darrell Patterson, Paul Murray, Andy Wells Intelligent Selection of Greener Solvents Centre for Sustainable Chemical technologies Doctoral Training Centre Summer Showcase, Bath, July 2014. 67). Dipolar Aprotic Solvents-Use In the Pharmaceutical Industry Centre for Sustainable Chemical technologies Doctoral Training Centre Summer Showcase, Bath, July 2014. 66). A review of the progress in solvent selection –dipolar aprotics and other solvents of concern Solvents Day, University of York, June 2014. 65). The biocatalysis toolbox - current successes and future victories SCI Process Chemistry Conference 2-4 April 2014, Cambridge, UK. 64). Biocatalytic Synthesis of Chiral Amines – Which Way to Choose?’ CatSci conference 2014 ‘Making Catalysis Work’, Cardiff, April 2014. 63). ‘Innovative Medicines Initiative: Sustainable chemical manufacturing methods for the 21st century pharmaceutical industries’ Green Initiatives in Energy, Environment & Health, New Delhi Dec 2-3 2013 62). ‘Expanding the Biocatalysis Tool Box - Both Breadth and Depth’ Ecochem Sunstainable manufacturing expo, 18-21 November 2013, Basel.
  10. 10. 61). ‘Trends in the adaption of green chemistry - chemical manufacturing methods for 21st century pharmaceutical industries’ Trends in Organic Chemistry, Swedish Chemical Society, Lund, April 2013. 60). Julia A. Griffen, Simon E. Lewis, Andrew Wells, Matthew D. Lloyd ‘Microbial Arene Oxidation; Sustainable routes to biologically active molecules’ 2012 Gordon Green Chemistry Research Conference, Italy. 59). ‘Fluorine – both sinner and saint atom in pharmaceuticals’ Bath University Organic Chemistry Seminar, Nov 2011. 58). M. Pourashraf, P. Turcotte, F. Samson-Thibault, A. Wells, M. Laplante, L-D Cantin, C. Walpole, M. Tomaszewski ‘Green chemistry at AstraZeneca R&D Montreal: Focus on solvent selection’ 242nd ACS National Meeting & Exposition, 2011. 57). Julia A. Griffen, Simon E. Lewis, Tom C. Arnot, Andy Wells ‘Microbial Arene Oxidation; Uses in Synthesis’ Centre for Sustainable Chemical Technologies Summer Showcase, Bath 2011. 56). ‘Drivers for increasing sustainability in the pharmaceutical industry’, Centre for Sustainable Chemical Technologies Summer Showcase, Bath 2011. 55). Conchita Jiménez-González, Peter Poechlauer, Rinus Broxterman, Bing-Shiou Yang, David am Ende, James Baird, Carl Bertsch , Bob Hanna, Phil Dell’Orco, Henk Noorman, Sandy Yee, Raf Reintjens , Andrew Wells, Vivianne Massonneau, Julie Manley ‘Key Green Engineering Research Areas’, 15TH Green Chemistry and Engineering Conference Washington, June 2011. 54). Neil Adlington, Eva Jakobsson, William Mckintosh, Andy Wells, Cecilia Frostne ’The use of second generation Ionic liquids and emerging dipolar aprotic solvents in organic synthesis’ 15TH Green Chemistry and Engineering Conference Washington, June 2011. 53). ‘Positives and negatives of using biocatalysis in the pharmaceutical Industry – why are we all not at it! Frontiers in Biocatalysis, TU Delft, June 2011. 52). ‘IB as a source of new drug leads and a low carbon manufacturing technology for pharmaceuticals and fine chemicals’ Industrial Biotechnology – a New Dawn for The Chemical Industry, CPI Wilton Centre, March 2011. 51). Julia A. Griffen, Tom C. Arnot, Andy Wells, Simon E. Lewis ‘Sustainable Routes to High Value Chiral Synthetic Intermediates’, Catalysis and Sensing for Health, Bath February 2011. 50). ‘Design of Greener synthetic routes and reduction and elimination of hazardous substances’ The 3rd International Workshop on Safety Technology for Pharmaceutical & Chemical Processes (STPCP 2010), Xi’An China Oct 2010. 49). ‘Environmental assessment of synthetic routes and identification and classification of hazardous substances’ The 3rd International Workshop on Safety Technology for Pharmaceutical & Chemical Processes (STPCP 2010), Xi’An China Oct 2010.
  11. 11. 48). ‘Biocatalysis: Present practice and future trends’ Biocatalysis: Challenges for Pharmaceuticals & Fine Chemicals, SCI conference, London, Oct 2010. 47). M. Pourashaf and A. Wells ‘Green Chemistry at AstraZeneca’ ACFAS, Montreal, May 2010. 46). ‘Towards more Sustainable Synthesis of Pharmaceuticals and Fine Chemicals’ 105th Korean Chemical Society Congress, Ihncion, Korea, April 2010. 45).‘Greener Technology – In Search of a more Sustainable Future’ Sungkyunkwan University, Seoul, Korea, April 2010. 44). ‘The Wonders of Biocatalysis’ Future of Industrial Biotechnology, Centre for Process Innovation, March 2010. 43). ‘Green Chemistry –Applications in Process Chemistry’ Tianjin University, China, Oct 2009. 42). ‘Some Applications of Biocatalysis in the synthesis of pharmaceuticals-present practice and future trends’ Asymchem Process Chemistry Symposium, 2009, Tianjin, China, Oct 2009. 41). Peter J. Dunn, Richard K. Henderson, Ingrid Mergelsberg, Andrew S. Wells ‘Moving towards Greener Solvents for Pharmaceutical Manufacturing – An Industry Perspective’ 13th Green Chemistry and Engineering Conference, College Park, MD, 2009. 40). ‘Synthetic Methodology Requirements - Power of partners-Shaping the Future’ Chemical Innovation –Knowledge Transfer Network annual meeting , June 2009. 39). ‘Strategies and Technologies for Greener Synthesis of Pharmaceuticals’ The State Research Centre of Industrialisation for Crystallisation Technology, Tianjin University, China, May 2009. 38). ‘Green Chemistry, Philosophy principles and Tools’ Working Together to Improve Environmental Performance – Chinese Society of Environmental Sciences/AstraZeneca, Beijing, China, May 2009. 37). ‘Biocatalysis, a Sustainable Technology for the Synthesis of Pharmaceuticals’ 2009 Pfizer Green chemistry Symposium, Pfizer GPS, Sandwich, Kent, UK, 2009. 36). ‘Towards Greener and more Sustainable Synthesis of Pharmaceuticals’ Manchester Literary and Philosophical Society – The Search for a Sustainable Future –Jan 2009. 35). ‘Greening Solvent Use in the Pharmaceutical Industry’ Green Solvents –Progress in Science and Application, DECHEMA, Friedrichshafen, Sept 2008. 34). ‘Some Applications of Biocatalysis in the Synthesis of Pharmaceutical Intermediates’, ACS ProSpectives Organic Reactions and Synthesis meeting Oct 2008, Philadelphia, USA, 2008. 33). ‘Biocatalytic Routes to the PPAR agonist AZD 4169’ Green Processing Symposium, Yale University May 2008.
  12. 12. 32). ‘Solvents in the Manufacture of Pharmaceuticals’ John Jeyes Symposium, Nottingham University, March 2008. 31). ‘Green Chemistry in the Pharmaceutical Industry’ 25th SCI Process Chemistry Symposium, Cambridge UK, December 2007. 30). ‘Prudent Practices for the Organic Chemist!’ Mike Williams Symposium, Pfizer, Sandwich UK, July 2007. 29). ‘UK Centre of Excellence in Biocatalysis,Biotransformations and Biocatalytic Manufacture –CoEBio3’ 11th Annual Green Chemistry and Engineering Conference, Washington DC, USA, June 2007. 28). ‘The Use of Lipases as Versatile Catalysts in the Preparation of Novel Oxazolidinone Antibacterials’ 11th Annual Green Chemistry and Engineering Conference, Washington DC, USA, June 2007. 27). ‘The Development of Generic Reaction Conditions for Metal-Catalysed Reactions’ 11th Annual Green Chemistry and Engineering Conference, Washington DC, USA, June 2007. 26). ‘Some Success Stories from AstraZeneca Green Chemistry Outreach Projects’International Symposium on Green Chemical Processes, Montreal, Oct 2006. 25). ‘Desiger Enzymes from Genes’ Department of Trade and Industry meeting, York University, September 2006. 24). ‘Biocatalysis, Current and Future use in Mainstream Manufacturing in the USA’, Department of Trade and Industry Global Watch Report September 2006. 23). Andrew S. Wells, Neil Adlington, Tove Åqvist ‘Green Oxidations in Organic Synthesis: Learning from Nature?’10th Annual Green Chemistry and Engineering Conference, Washington, USA, June 2006. 22). Andrew S. Wells, Paul Bainbridge, Neil Adlington ‘Pharmaceuticals in the Environment: Development of an Active Pharmaceutical Ingredient (API) Waste Treatment Software Tool’ 10th Annual Green Chemistry and Engineering Conference, Washington, USA, June 2006. 21). ‘Biocatalysts, Current and Future use in Mainstream Manufacturing’ US-UK Biocatalysis Conference, , British Consulate General, Boston, MA, May 26th 2006. 20). L. L. Woodcock, G. M. Greenway, P. Watts, A. Wells and S. Eyley ‘Application of Microreactors for Biocatalysis’ Biocatalysis: Enzymes, Mechanisms and Bioprocesses Biochemical Society Meeting in association with Pro-Bio Faraday Annual Conference – Manchester, November 2005.
  13. 13. 19). Andy Wells, Tom Eve and Maira Teria ‘Green Oxidations using Laccase –Mediator Systems’ Biocatalysis: Enzymes, Mechanisms and Bioprocesses, Biochemical Society Meeting in association with Pro-Bio Faraday Annual Conference – Manchester, November 2005. 18). A. Wells and Vyv Coombe ‘On the Freshwater Ecotoxicity of some Common Ionic Liquids’ 2nd International Conference on Green and Sustainable Chemistry, Washington D.C., June 2005. 17). Pete Clark, Martyn Poliakoff and Andy Wells ‘Chemoselective Debenzylation of Phamaceutical Intermediates in Supercritical CO2’ CONNECT 2005, Royal Australian Chemistry Institute, July 2005. 16). ‘The Application of Fluorine Chemistry in the Pharmaceutical Industry’ CRYSTAL Faraday 1st ‘Fluorum’ meeting, Syngenta, Jelott’s Hill, UK, April 2005. 15). ‘The Value of Biocatalysis in the Manufacture of Fine Chemicals’ New Challenges in Synthesis for Pharmaceutical Products- Singapore Feb 2005 ASTAR/RSC workshop. 14). T. S. Eve, N. J. Turner and Andrew Wells, ‘Towards a Deracemisation of Hydroxylamine Derivatives’ Pro-Bio Annual Conference, Warwick, UK, November 2004. 13). ‘Some Industrial Applications of Hydrolytic Enzymes in Japan’ DTI -Global Watch Specialised Bioprocessing and Manufacturing: The Japanese Perspective, London, September 2004. 12). Pete Clark, Martyn Poliakoff and Andy Wells ‘Transformation of Pharmaceutically Active Materials in Supercritical CO2’ INCA 7th Summer School on Green Chemistry, Venice, Sept 2004. 11). ‘The Impact of Industrial Biotechnology on the Sustainability of the Manufacturing Base’ Department of Trade and Industry Global Watch Report, September 2004. 10). ‘Use of Lipases as non-chiral catalysts in the synthesis of a Novel Antibacterial’ New Perspectives in Medicinal Chemistry, Romark Laboratories Symposium , Liverpool, May 2004. 9). ‘Synthesis of Intermediates and Active Pharmaceuticals using Biocatalysis’ British Embassy, Toyko, 24th April 2004. 8) D. A. Pears and Andy Wells ‘Polyurea Microencapsulated Catalysts’ 21ST SCI Process Chemistry Symposium, Cambridge, Dec 2003. 6). ‘Baker’s Yeast reduction of Aromatic Nitro Compounds’ Effecting Change-Biocatalysis for the 21st Century –Manchester, 2002. 5). ‘The use of Biocatalysis in Manufacturing Processes – a Process Chemists View’ Pro-Bio Faraday Workshop, Warwick, 2002.
  14. 14. 4) S. Rafiq, N. Turner and A. Wells, ‘Microbial Reduction of Aromatic Nitro Groups using Saccharomyces Cerevisiae’ Biotrans '99 , Italy. 3) M. L. Gradley, K. Lawrie, A. Wells and J. Sime, ‘Applications for Selective Nitrile Bioconversions ’ INBIO Europe '99. 2). J. Blackie, N. J. Turner and A. Wells, ‘Baker's Yeast Reduction of Aromatic Nitro Compounds’ Biochemical Engineering, Minnesota, 1997. 1).J. S. McGuinn, N. J. Turner and A. S. Wells, ‘Microbial Reduction of Carbon-Carbon Double Bonds’, Biotrans' 97,France. ‘ .
  15. 15. .

×